Skip to main content

Table 1 Baseline characteristics of advanced squamous cell carcinoma of the hypopharynx by primary treatment.

From: Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma

Variable

All

Surgery

CCRT

n

(%)

n

(%)

n

(%)

Total

652

 

213

 

439

 

Sex

 Female

13

(2.0)

1

(7.7)

12

(92.3)

 Male

639

(98.0)

212

(33.2)

427

(66.8)

Age (years)

 < 65

565

(86.7)

184

(32.6)

381

(67.4)

 ≥ 65

87

(13.3)

29

(33.3)

58

(66.7)

 Mean (SD)

53

(10.0)

53

(9.6)

53

(10.3)

T classification

 T1

30

(4.6)

10

(33.3)

20

(66.7)

 T2

81

(12.4)

23

(28.4)

58

(71.6)

 T3

146

(22.4)

63

(43.2)

83

(56.8)

 T4

395

(60.6)

117

(29.6)

278

(70.4)

N classification

 N0

100

(15.3)

30

(30.0)

70

(70.0)

 N1

99

(15.2)

48

(48.5)

51

(51.5)

 N2

369

(56.6)

127

(34.4)

242

(65.6)

 N3

84

(12.9)

8

(9.5)

76

(90.5)

Overall stages

 III

91

(14.0)

44

(48.4)

47

(51.6)

 IVA

412

(63.2)

147

(35.7)

265

(64.3)

 IVB

149

(22.8)

22

(14.8)

127

(85.2)

Histology grade

 WD/MD SCC

360

(55.2)

177

(49.2)

183

(50.8)

 PD/UD

90

(13.8)

27

(30.0)

63

(70.0)

 Unclassified

202

(31.0)

9

(4.5)

193

(95.5)

  1. CCRT concurrent chemoradiotherapy, WD well-differentiated squamous cell carcinoma, MD moderately differentiated squamous cell carcinoma, PD poorly differentiated squamous cell carcinoma, UD undifferentiated carcinoma